166 related articles for article (PubMed ID: 15168341)
1. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression.
Slowińska-Klencka D; Klencki M; Popowicz B; Sporny S; Lewiński A
Histol Histopathol; 2004 Jul; 19(3):785-92. PubMed ID: 15168341
[TBL] [Abstract][Full Text] [Related]
2. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions.
Słowińska-Klencka D; Klencki M; Popowicz B; Lewiński A
Anal Quant Cytol Histol; 2003 Dec; 25(6):347-52. PubMed ID: 14714301
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland.
Zaczek M; Szot W; Chłap Z
Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of AgNOR staining in thyroid cytology.
Shechtman L; Koren R; Horowitz A; Shechtman I; Halpern M; Gal R
Anal Quant Cytol Histol; 1998 Jun; 20(3):187-91. PubMed ID: 9642445
[TBL] [Abstract][Full Text] [Related]
5. Fine needle aspiration cytology combined with argyrophilic nucleolar organizer regions (AgNORs) in diagnosis of thyroid neoplasms.
Szot W; Szybiński Z; Zaczek M; Kedra D; Dabroś E; Piotrowska K; Chłap Z
Endokrynol Pol; 1993; 44(4):413-26. PubMed ID: 7519978
[TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organizing region associated protein synthesis for cytologic discrimination of follicular thyroid lesions.
Oktay M; Eroz R; Oktay NA; Erdem H; Başar F; Akyol L; Cucer N; Bahadir A
Biotech Histochem; 2015 Apr; 90(3):179-83. PubMed ID: 25420891
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods.
Augustynowicz A; Dziecioł J; Barwijuk-Machała M; Dadan J; Puchalski Z; Sulkowski S
Folia Histochem Cytobiol; 2004; 42(3):165-8. PubMed ID: 15493577
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features.
Rüschoff J; Prasser C; Cortez T; Höhne HM; Hohenberger W; Hofstädter F
Am J Surg Pathol; 1993 Dec; 17(12):1281-8. PubMed ID: 8238736
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the nucleolar organizer regions (NORs) in the thyroid follicular tumours. Comparison of the cytological and histopathological examinations.
Musiatowicz B; Dziecioł J; Augustynowicz A; Miller-Famulska D; Sulik M; Famulski W; Chabowski A; Jabłońska E; Andrzejewicz A; Mielech W; Guzińska-Ostymowicz K
Rocz Akad Med Bialymst; 1998; 43():186-93. PubMed ID: 9972054
[TBL] [Abstract][Full Text] [Related]
10. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
Zaczek M
Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
[TBL] [Abstract][Full Text] [Related]
11. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity of the thyroid oxyphilic tumor cells estimated by means of quantitative analysis of silver stained nucleolar organizer regions (AgNORs).
Augustynowicz A; Dziecioł J; Dadan J; Puchalski Z; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():203-4. PubMed ID: 11820609
[TBL] [Abstract][Full Text] [Related]
14. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
Mehrotra A; Goel MM; Singh K
Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
[TBL] [Abstract][Full Text] [Related]
16. Significance of AgNOR measurement in thyroid lesions.
Camargo RS; Shirata NK; di Loreto C; Garcia EA; Castelo A; Longatto Filho A
Anal Quant Cytol Histol; 2006 Aug; 28(4):188-92. PubMed ID: 16927638
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
Lewy-Trenda I; Bieńkiewicz M
Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of RET immunostaining in follicular lesions of the thyroid.
Cerilli LA; Mills SE; Rumpel CA; Dudley TH; Moskaluk CA
Am J Clin Pathol; 2002 Aug; 118(2):186-93. PubMed ID: 12162676
[TBL] [Abstract][Full Text] [Related]
19. Cytopathology and AgNOR counts in fine-needle aspiration cytology smears of thyroid lesions.
Mehrotra A; Agarwal PK; Chandra T
Diagn Cytopathol; 1998 Oct; 19(4):238-43. PubMed ID: 9784984
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of cytoplasmic yellow bodies in thyroid neoplasms.
Rothenberg HJ; Goellner JR; Carney JA
Arch Pathol Lab Med; 2003 Jun; 127(6):715-7. PubMed ID: 12741896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
